__NUXT_JSONP__("/drugs/Aglatimagene_Besadenovec", (function(a,b,c,d){return {data:[{drug:{slug:a,emaEpar:[],fdaDrugLabel:[],id:a,nciThesaurus:{casRegistry:"1621271-62-2",chebiId:b,chemicalFormula:b,definition:"An adenoviral vector engineered to express the herpes simplex virus thymidine kinase (HSV-tk) gene, which, when administered in conjunction with a synthetic acyclic guanosine analogue, possesses potential antineoplastic activity. Aglatimagene besadenovec is transduced into tumor cells, sensitizing tumor cells that overexpress HSV-tk to synthetic acyclic guanosine analogues. Subsequently, a low dose of a synthetic acyclic guanosine analogue such as valacyclovir (VCV) or ganciclovir (GCV) is given, which may preferentially kill tumor cells containing the adenoviral vector and overexpressing HSV-tk. Release of tumor-associated antigens (TAAs) by dying tumor cells may then stimulate an antitumor cytotoxic T lymphocyte (CTL) response.",fdaUniiCode:"5Z72SSS34W",identifier:"C73996",preferredName:c,semanticType:"Pharmacologic Substance",subclassOf:["C129820","C1962","C61199"],synonyms:["ADV-tk","AGLATIMAGENE BESADENOVEC",c,"GliAtak","ProstAtak","Virafir"]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FAglatimagene_Besadenovec",extension:".json",createdAt:d,updatedAt:d}}],fetch:{},mutations:void 0}}("Aglatimagene_Besadenovec","","Aglatimagene Besadenovec","2021-10-30T13:44:10.383Z")));